Tirzepatide (Tirz)
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide. It was originally developed as a type 2 diabetes treatment (marketed as Mounjaro) and is also approved for chronic weight management (Zepbound). It mimics two incretin hormones to regulate blood sugar and body weight.
Choose your dosage
Purity: 99%
Form: Lyophilized Powder
Description
DEFINITION
Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide. It was originally developed as a type 2 diabetes
treatment (marketed as Mounjaro) and is also approved for chronic weight management (Zepbound). It mimics
two incretin hormones to regulate blood sugar and body weight.
KEY BENEFITS
■Substantial weight loss — up to 20–22% body weight in clinical studies
â– Significant improvement in HbA1c and blood glucose levels
â– Reduction in cardiovascular risk factors including blood pressure and triglycerides
â– Decreased appetite and improved satiety signaling
â– Positive effects on liver fat accumulation
Available Quantities
30mg
